SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Pitts Reynaria)
 

Sökning: WFRF:(Pitts Reynaria) > Aldosterone Does No...

  • Pitts, ReynariaVA Medical Centre, CO USA; University of Colorado, CO USA (författare)

Aldosterone Does Not Predict Cardiovascular Events Following Acute Coronary Syndrome in Patients Initially Without Heart Failure

  • Artikel/kapitelEngelska2017

Förlag, utgivningsår, omfång ...

  • WILEY-BLACKWELL,2017
  • electronicrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:liu-135708
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-135708URI
  • https://doi.org/10.1161/JAHA.116.004119DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Funding Agencies|F. Hoffmann-La Roche
  • Background- Aldosterone may have adverse effects in the myocardium and vasculature. Treatment with an aldosterone antagonist reduces cardiovascular risk in patients with acute myocardial infarction complicated by heart failure (HF) and left ventricular systolic dysfunction. However, most patients with acute coronary syndrome do not have advanced HF. Among such patients, it is unknown whether aldosterone predicts cardiovascular risk. Methods and Results- To address this question, we examined data from the dal-OUTCOMES trial that compared the cholesteryl ester transfer protein inhibitor dalcetrapib with placebo, beginning 4 to 12 weeks after an index acute coronary syndrome. Patients with New York Heart Association class II (with LVEF amp;lt; 40%), III, or IV HF were excluded. Aldosterone was measured at randomization in 4073 patients. The primary outcome was a composite of coronary heart disease death, nonfatal myocardial infarction, stroke, hospitalization for unstable angina, or resuscitated cardiac arrest. Hospitalization for HF was a secondary endpoint. Over a median follow-up of 37 months, the primary outcome occurred in 366 patients (9.0%), and hospitalization for HF occurred in 72 patients (1.8%). There was no association between aldosterone and either the time to first occurrence of a primary outcome (hazard ratio for doubling of aldosterone 0.92, 95% confidence interval 0.78-1.09, P=0.34) or hospitalization for HF (hazard ratio 1.38, 95% CI 0.96-1.99, P=0.08) in Cox regression models adjusted for covariates. Conclusions- In patients with recent acute coronary syndrome but without advanced HF, aldosterone does not predict major cardiovascular events.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Gunzburger, EliseUniversity of Colorado, CO USA (författare)
  • Ballantyne, Christie M.Baylor Coll Med, TX 77030 USA (författare)
  • Barter, Philip J.University of New South Wales, Australia (författare)
  • Kallend, DavidMedicines Co, Switzerland (författare)
  • Leiter, Lawrence A.University of Toronto, Canada; University of Toronto, Canada (författare)
  • Leitersdorf, EranHadassah Hebrew University, Israel (författare)
  • Nicholls, Stephen J.University of Adelaide, Australia; University of Adelaide, Australia (författare)
  • Shah, Prediman K.Cedars Sinai Heart Institute, CA USA (författare)
  • Tardif, Jean-ClaudeUniversity of Montreal, Canada (författare)
  • Olsson, Anders,1940-Linköpings universitet,Avdelningen för kardiovaskulär medicin,Medicinska fakulteten,Region Östergötland, Endokrinmedicinska kliniken(Swepub:liu)andol21 (författare)
  • McMurray, John J. V.University of Glasgow, Scotland (författare)
  • Kittelson, JohnUniversity of Colorado, CO USA (författare)
  • Schwartz, Gregory G.VA Medical Centre, CO USA; University of Colorado, CO USA (författare)
  • VA Medical Centre, CO USA; University of Colorado, CO USAUniversity of Colorado, CO USA (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Journal of the American Heart Association: WILEY-BLACKWELL6:12047-9980

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy